During tumor progression, CAAs support CRC onco-inflammatory milieu through release of proinflammatory cytokines, including IL1-β, IL-6, IL-8, and TNF-α that modulate the innate and adaptive immune response (Figure 4) [28]. The gene discussed is IL6; the disease is colorectal carcinoma.